ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO
Why now
Thesis: ADARx surges in upsized Nasdaq debut
Catalyst to watch: Post-IPO analyst coverage
Main risk: Early pop may fade post-lockup
Why it matters
ADARx shares soar in Nasdaq debut after upsized IPO, signaling strong biotech IPO demand.
Sources
- googlenews · news.google.com · 2026-09-25 16:21 UTC
- googlenews · news.google.com · 2026-09-25 16:21 UTC
- googlenews · news.google.com · 2026-09-25 16:21 UTC